Painful diabetic peripheral neuropathy (PDPN) is present in nearly a quarter of people with
diabetes. It is estimated to affect over 100 million people worldwide. PDPN is associated …

Peripheral neuropathy affects about 30% of people with diabetes mellitus. Between 16%
and 26% of diabetes patients experience chronic pain. This may be referred to as diabetic …

Painful diabetic peripheral neuropathy (DPN) is common, is associated with significant
reduction in quality of life and poses major treatment challenges to the practising physician …

Purpose Diabetic peripheral neuropathy (DPN) is the commonest cause of neuropathy
worldwide, and its prevalence increases with the duration of diabetes. It affects …

Painful diabetic neuropathy (PDN) is one of several clinical syndromes in patients with
diabetic peripheral neuropathy (DPN) and presents a major challenge for optimal …

The treatment of painful diabetic polyneuropathy (PDPN) remains a major challenge. A
number of reasons have made the guidelines on PDPN management of particular interest …

There is a high prevalence of painful diabetic polyneuropathy (pDPN) with around one-third
of all patients with diabetes suffering from pDPN. pDPN has debilitating consequences, with …

Painful diabetic peripheral neuropathy (DPN) is described as a superficial burning pain
associated with other positive and/or negative sensory systems affecting the feet and lower …

Painful diabetic peripheral neuropathy (painful-DPN) is a highly prevalent and disabling
condition, affecting up to one-third of patients with diabetes. This condition can have a …

Diabetic peripheral neuropathy (DPN) is one of the most prevalent chronic complications of
diabetes. The lifetime prevalence of DPN is thought to be> 50%, and 15%–25% of patients …